Correlation Between Sartorius Stedim and ESSILORLUXOTTICA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sartorius Stedim and ESSILORLUXOTTICA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sartorius Stedim and ESSILORLUXOTTICA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sartorius Stedim Biotech and ESSILORLUXOTTICA 12ON, you can compare the effects of market volatilities on Sartorius Stedim and ESSILORLUXOTTICA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sartorius Stedim with a short position of ESSILORLUXOTTICA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sartorius Stedim and ESSILORLUXOTTICA.

Diversification Opportunities for Sartorius Stedim and ESSILORLUXOTTICA

-0.11
  Correlation Coefficient

Good diversification

The 3 months correlation between Sartorius and ESSILORLUXOTTICA is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Sartorius Stedim Biotech and ESSILORLUXOTTICA 12ON in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ESSILORLUXOTTICA 12ON and Sartorius Stedim is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sartorius Stedim Biotech are associated (or correlated) with ESSILORLUXOTTICA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ESSILORLUXOTTICA 12ON has no effect on the direction of Sartorius Stedim i.e., Sartorius Stedim and ESSILORLUXOTTICA go up and down completely randomly.

Pair Corralation between Sartorius Stedim and ESSILORLUXOTTICA

Assuming the 90 days trading horizon Sartorius Stedim Biotech is expected to under-perform the ESSILORLUXOTTICA. In addition to that, Sartorius Stedim is 2.2 times more volatile than ESSILORLUXOTTICA 12ON. It trades about -0.02 of its total potential returns per unit of risk. ESSILORLUXOTTICA 12ON is currently generating about 0.05 per unit of volatility. If you would invest  8,643  in ESSILORLUXOTTICA 12ON on September 1, 2024 and sell it today you would earn a total of  2,657  from holding ESSILORLUXOTTICA 12ON or generate 30.74% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Sartorius Stedim Biotech  vs.  ESSILORLUXOTTICA 12ON

 Performance 
       Timeline  
Sartorius Stedim Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sartorius Stedim Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Sartorius Stedim is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
ESSILORLUXOTTICA 12ON 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in ESSILORLUXOTTICA 12ON are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile essential indicators, ESSILORLUXOTTICA may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Sartorius Stedim and ESSILORLUXOTTICA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sartorius Stedim and ESSILORLUXOTTICA

The main advantage of trading using opposite Sartorius Stedim and ESSILORLUXOTTICA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sartorius Stedim position performs unexpectedly, ESSILORLUXOTTICA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ESSILORLUXOTTICA will offset losses from the drop in ESSILORLUXOTTICA's long position.
The idea behind Sartorius Stedim Biotech and ESSILORLUXOTTICA 12ON pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Money Managers
Screen money managers from public funds and ETFs managed around the world
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Stocks Directory
Find actively traded stocks across global markets